/PDAC.TME.George

Primary LanguageHTMLOtherNOASSERTION

N|Solid

PDAC Tumor Microenvironment Classification

This repository contains the code and resources for classifying the tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) based on functional gene signatures (FGEs) calculated on bulk RNA-Seq or microarray gene expressions data.

Overview

PDAC presents a complex tumor environment, which has historically posed challenges in the development of reliable predictive biomarkers for targeted therapies and immunomodulation. To address this, we've implemented a classification approach based on transcriptomic profiling of the TME.

Four TME subtypes were developed:

  • Immune Enriched (IE)
  • Immune Enriched, Fibrotic (IE/F)
  • Fibrotic (F)
  • Immune Depleted (D)

Publication

Developed classification is described in details in [DOI link - TODO]

plot

Features

This repository contains:

  • Data
    • PDAC Meta-Cohort: annotation & calculated FGEs for all samples
    • ICGC PACA-CA (test cohort): annotation & expressions
  • Genesets
    • genesets/PAAD_genesets.gmt - table of all used genesets
  • Code
    • utils/ - scripts for data preprocessing, ssGSEA score calculation, median scaling and plots
    • Notebook MFP_TME_classificataion.ipynb with a classification of ICGC PACA-CA samples into four TME subtypes using supervised clustering

Getting Started

Prerequisites

  • Python 3.x - Python 3.9 is advised
  • Required Python libraries: please see requirements.txt

Installation

Clone the repository:

git clone https://github.com/BostonGene/PDAC.TME.George.git

Navigate to the repository directory:

cd PDAC.TME.George

Install required dependencies:

python3.9 -m venv venv  
source venv/bin/activate  
venv/bin/python3.9 -m pip install --upgrade pip  
pip install --no-deps -r requirements.txt  
jupyter nbextension enable --py widgetsnbextension  
python -m ipykernel install --user --name=pdac_tme_venv 

License

Licensed by BostonGene Licence -- for more info please see LICENSE file
Please direct any inquiries concerning usage to askusepermission@bostongene.com.
© 2023 BostonGene Corporation.